PH18345A - Novel arcylimidazole-2-ones - Google Patents

Novel arcylimidazole-2-ones

Info

Publication number
PH18345A
PH18345A PH26929A PH26929A PH18345A PH 18345 A PH18345 A PH 18345A PH 26929 A PH26929 A PH 26929A PH 26929 A PH26929 A PH 26929A PH 18345 A PH18345 A PH 18345A
Authority
PH
Philippines
Prior art keywords
ones
arcylimidazole
novel
aroylimidazole
cardiotonics
Prior art date
Application number
PH26929A
Other languages
English (en)
Inventor
Richard C Dage
Frank P Palopoli
Richard A Schnettler
Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH18345A publication Critical patent/PH18345A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PH26929A 1981-03-05 1982-03-01 Novel arcylimidazole-2-ones PH18345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (1)

Publication Number Publication Date
PH18345A true PH18345A (en) 1985-06-05

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26929A PH18345A (en) 1981-03-05 1982-03-01 Novel arcylimidazole-2-ones

Country Status (18)

Country Link
US (1) US4405628A (OSRAM)
EP (1) EP0059948B1 (OSRAM)
KR (1) KR890000765B1 (OSRAM)
AT (1) ATE16489T1 (OSRAM)
AU (1) AU557590B2 (OSRAM)
CA (1) CA1190550A (OSRAM)
DE (1) DE3267352D1 (OSRAM)
DK (1) DK168627B1 (OSRAM)
ES (2) ES8305352A1 (OSRAM)
GB (1) GB2096600B (OSRAM)
GR (1) GR76518B (OSRAM)
HK (1) HK61686A (OSRAM)
IE (1) IE52387B1 (OSRAM)
IL (1) IL65137A (OSRAM)
MY (1) MY8600700A (OSRAM)
NO (1) NO157175C (OSRAM)
NZ (1) NZ199885A (OSRAM)
PH (1) PH18345A (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
IL75902A (en) * 1984-07-30 1988-10-31 Merrell Dow Pharma Preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
EP0536279A1 (en) * 1990-06-29 1993-04-14 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2559319T3 (es) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
CN105979959B (zh) 2013-08-09 2021-11-30 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
EP0059948B1 (en) 1985-11-13
ATE16489T1 (de) 1985-11-15
GB2096600B (en) 1985-06-05
NZ199885A (en) 1985-04-30
HK61686A (en) 1986-08-29
ES8402827A1 (es) 1984-03-01
NO157175B (no) 1987-10-26
DK95482A (da) 1982-09-06
ES510087A0 (es) 1983-04-16
ES519254A0 (es) 1984-03-01
AU8103782A (en) 1982-09-09
DK168627B1 (da) 1994-05-09
AU557590B2 (en) 1986-12-24
ES8305352A1 (es) 1983-04-16
NO820686L (no) 1982-09-06
IL65137A0 (en) 1982-05-31
KR890000765B1 (ko) 1989-04-05
MY8600700A (en) 1986-12-31
US4405628A (en) 1983-09-20
NO157175C (no) 1988-02-03
CA1190550A (en) 1985-07-16
EP0059948A1 (en) 1982-09-15
IL65137A (en) 1987-02-27
DE3267352D1 (en) 1985-12-19
IE820491L (en) 1982-09-05
IE52387B1 (en) 1987-10-14
GR76518B (OSRAM) 1984-08-10
GB2096600A (en) 1982-10-20
KR830009046A (ko) 1983-12-17

Similar Documents

Publication Publication Date Title
DE3267352D1 (en) Novel aroylimidazolones
ZA837976B (en) Imidazolylalkylthienyl-tetrahydropyridazines and processes for their preparation
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
ATE7387T1 (de) Herstellung des calciumsalzes von alpha-hydroxy- gamma-methylmercaptobuttersaeure.
JPS57122085A (en) Circulatory disease extirpenter and use
IE822519L (en) Phosphonic acid derivatives
NO864514D0 (no) Fremgangsmaate for fremstilling av thiazoloner.
ES530677A0 (es) Procedimiento de laminado universal integral de perfilados metalicos del tipo vigueta en h o i
ATE79615T1 (de) Cardiotonische phenyloxazolone.
DE3373978D1 (en) Composition for the care or treatment of the human skin
IT1221010B (it) Impiego di chinoloni nel trattamento di malattie cardiache
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
GR77250B (OSRAM)
DE3776488D1 (OSRAM)
IT8324141A0 (it) Preparato per la cura delle ustioni.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
ATE64683T1 (de) Zusammensetzung zur behandlung von haemorroiden.